24 - 25 August 2020 | BST (UTC+1)
Join over 600 leaders at the forefront of research into the immune system, connecting experts from pharma, biotech and academia working on the delivery of innovative immunotherapies
The Immuno Series features 2 outstanding programmes consisting of key discussion topics in Immuno-Oncology, Autoimmunity, Immunology and Inflammation, enabling attendees to gain actionable insights into the approaches impacting this field from the leading immunotherapy experts.
The 2020 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
AstraZeneca
F. Hoffmann-La Roche Ltd.
BMS
MHRA
Boehringer Ingelheim
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of virtual experiences.
We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.
With a key priority in the IO industry centring around developing effective combination therapies, we are currently preparing a detailed market survey to provide the community with insights from leading experts into their strategies for this, the technologies they require and any bottlenecks.
Have your say in our Immuno-Oncology Market Survey & win an iPad Mini 4!
